USPTO 2015–2025 USPTO PatentsView Foreign Corporation

FIDIA FARMACEUTICI S.p.A.

USPTO PatentsView assignee record — 49 granted patents across 21 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

49
Total patents granted
21
CPC technology areas
11.6
Avg claims per patent
-19%
5-year filing velocity

Portfolio overview

FIDIA FARMACEUTICI S.p.A. has been granted 49 US utility patents between 2015 and 2025, placing FIDIA FARMACEUTICI S.p.A. at rank #6,770 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, FIDIA FARMACEUTICI S.p.A. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 40.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 22 grants, compared with 27 in the 2015–2019 window — a -19% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. FIDIA FARMACEUTICI S.p.A.'s 11.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark FIDIA FARMACEUTICI S.p.A. against peers pursuing similar technology classes.

How does FIDIA compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows FIDIA holds 49 patents — placing it at rank #6,770 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

0246810 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
FIDIA FARMACEUTICI S.p.A. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 8.2%
2016 6 12.2%
2017 8 16.3%
2018 4 8.2%
2019 5 10.2%
2020 5 10.2%
2021 5 10.2%
2022 4 8.2%
2023 2 4.1%
2024 2 4.1%
2025 4 8.2%

Which technologies does FIDIA FARMACEUTICI S.p.A. patent most?

Top 15 of 21 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Declining

Where it ranks

Overall rank by patents

#6,770

Across all tracked assignees

Innovation Score

40.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does FIDIA FARMACEUTICI S.p.A. hold?
FIDIA FARMACEUTICI S.p.A. holds 49 US granted patents filed between 2015 and 2025, spanning 21 technology areas.
What is FIDIA FARMACEUTICI S.p.A.'s Innovation Score?
FIDIA FARMACEUTICI S.p.A. has an Innovation Score of 40.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does FIDIA FARMACEUTICI S.p.A. focus on?
FIDIA FARMACEUTICI S.p.A.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 43 patents. The company has filed patents in 21 CPC subclasses total.
Is FIDIA FARMACEUTICI S.p.A.'s patent filing rate increasing or decreasing?
FIDIA FARMACEUTICI S.p.A.'s recent filing velocity is -19% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for FIDIA FARMACEUTICI S.p.A.'s patents?
FIDIA FARMACEUTICI S.p.A.'s patents average 11.6 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the FIDIA FARMACEUTICI S.p.A. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope